BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 29392828)

  • 1. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
    Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
    ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer treatment-related arm lymphoedema and morbidity: A 6-year experience in an Australian tertiary breast centre.
    Huang YY; Toh PY; Hunt C; Lin JTW; Kamyab R; Ponniah AK
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):109-117. PubMed ID: 33629541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
    Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
    Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.
    Parks RM; Cheung KL
    Breast; 2017 Jun; 33():57-70. PubMed ID: 28282588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.
    Burak WE; Hollenbeck ST; Zervos EE; Hock KL; Kemp LC; Young DC
    Am J Surg; 2002 Jan; 183(1):23-7. PubMed ID: 11869698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
    Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Che Bakri NA; Kwasnicki RM; Khan N; Ghandour O; Lee A; Grant Y; Dawidziuk A; Darzi A; Ashrafian H; Leff DR
    Ann Surg; 2023 Apr; 277(4):572-580. PubMed ID: 35946806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB.
    Belmonte R; Messaggi-Sartor M; Ferrer M; Pont A; Escalada F
    Support Care Cancer; 2018 Sep; 26(9):3277-3287. PubMed ID: 29651594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery.
    Sackey H; Johansson H; Sandelin K; Liljegren G; MacLean G; Frisell J; Brandberg Y
    Eur J Surg Oncol; 2015 Apr; 41(4):577-84. PubMed ID: 25659877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.
    Kootstra JJ; Dijkstra PU; Rietman H; de Vries J; Baas P; Geertzen JH; Hoekstra HJ; Hoekstra-Weebers JE
    Breast Cancer Res Treat; 2013 May; 139(1):125-34. PubMed ID: 23588950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arm lymphoedema after axillary surgery in women with invasive breast cancer.
    Sackey H; Magnuson A; Sandelin K; Liljegren G; Bergkvist L; Fülep Z; Celebioglu F; Frisell J
    Br J Surg; 2014 Mar; 101(4):390-7. PubMed ID: 24536010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
    Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ
    Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
    Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
    Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
    Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
    Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
    Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
    Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.